On the basis of previous indirect measurements, skeletal muscle has been implicated as the major site of glucose uptake and it has been suggested that muscle glycogen formation is the dominant pathway. However, direct measurements of the rates of glycogen synthesis have not been possible by previous techniques. We have developed 13C NMR methods to measure directly the rate of human muscle glycogen formation from infused, isotopically labeled [1-13C]glucose. We show that under conditions of imposed hyperglycemia and hyperinsulinemia, a majority of the infused glucose was converted to muscle glycogen in a normal man. This directly shows that muscle is the major site of glucose disposal under these conditions, and provides quantitation of the glucose flux to muscle glycogen.
The maintenance of normal plasma glucose concentration after a glucose load depends upon three processes that occur simultaneously and in a coordinated fashion: (i) insulin secretion, (ii) suppression of hepatic glucose production, and (iii) glucose uptake by peripheral (muscle) and liver tissues (1) . Arterial/venous difference measurements of liver and muscle have given evidence that the majority of the glucose load, whether given orally or intravenously, is disposed of by muscle (2) (3) (4) (5) . Once taken up by muscle, glucose can be either oxidized into C02, stored in muscle as glycogen or fat, or released into the blood as lactate. Indirect measurements of 02 consumption have shown that the majority of the glucose is not oxidized (1, 4, 6) . Although it has been suggested that muscle glycogen is the primary storage compound, direct measurements of muscle glycogen formation in humans have yielded variable results (7) (8) (9) (10) . Even at whole-body glucose disposal rates above those likely to be encountered in everyday life, it has been difficult to demonstrate a significant increase in muscle glycogen concentration in response to insulin (9, 10) . Until now quantitation of muscle glycogen synthesis has relied upon the ability to detect a small increment in the glycogen concentration in muscle biopsy samples obtained before and after an experimental maneuver. This has presented two problems. First, the expected increase in muscle glycogen concentration under physiologic conditions is less than the accuracy of currently available assays for the determination of unlabeled glycogen concentration. Second, the biopsy technique is invasive and repetitive sampling cannot be performed. This makes detailed kinetic studies impossible. In this report we show that '3C nuclear magnetic resonance (NMR) spectroscopy can measure glycogen synthesis rates in a normal human with 15.5-min time resolution.
Although the glycogen molecule has a high molecular weight, it has been shown to be 100o 13C NMR- The study began at 0800 following a 10-hr fast. Catheters were inserted into each antecubital vein for the infusion of test substances and blood withdrawal. After a 62-min baseline period during which four consecutive muscle glycogen signal accumulations were obtained from the naturalabundance '3C nuclei, a hyperglycemic, hyperinsulinemic "clamp" was imposed (4, 17) . At time zero a primecontinuous (1 milliunit per kg per min) infusion of insulin was administered to rapidly raise the plasma insulin concentration by approximately 70 microunits/ml above baseline for 180 min. At the same time a prime glucose infusion was given over 10 min to raise the plasma glucose concentration rapidly to 200 mg/dl. Thereafter, the plasma glucose concentration was measured every 5 min and a variable glucose infusion was adjusted to maintain the desired hyperglycemic level for 170 min. During the first 100 min all ofthe infused glucose was enriched to 8.7% with [1-_3C] (2, 3) showed that hepatic glucose production is suppressed under these hyperglycemic, hyperinsulinemic conditions. Natural-abundance '3C reference spectra were acquired before the infusion of glucose and insulin. A typical baseline spectrum is shown in Fig. 1 , spectrum A. Within 15 min after the start of the insulin/glucose infusion, the C-1 glycogen signal began to increase. After 100 min, the glycogen signal had increased by a factor of 3 above the basal level (spectrum B). The spectral difference between the 100-min and baseline §To whom reprint requests should be addressed. 1 . Natural-abundance 13C spectra were collected on a 1-m-bore, 2.1-T Biospec spectrometer. An 8-cm 13C circular surface coil was used for both transmitting and receiving. A 13-cm concentric circular surface coil tuned to the 1H frequency was used for decoupling. The coil was made from 99.9o pure copper wire (2.5 mm in diameter). At the coil center the loaded 900 pulse was 150 usec for 1H and 120 sec for 13C. The rf transmitter power was 400 W. For single-frequency 1H decoupling, 10 W was applied only during acquisition (20% duty cycle). The total heat deposition did not exceed the Food and Drug Administration guideline of 8 W/kg of tissue. The subject's right gastrocnemius muscle was placed atop the surface coil, separated by a 6-mm Lucite plate. Velcro straps anchored the leg in order to minimize motion during the experiment. The magnet was shimmed using the leg H20 signal observed with the 1H coil. 13C spectra were acquired with a 1-t-1 sequence, which was tailored to excite the 100-ppm region and to minimize the 30-ppm lipid region. Each pulse was 75 ,usec. Interpulse delay was 320,sec. The repetition time of 80 msec was optimized for the C-1 glycogen signal, which has relaxation times T, = 240 msec and T2 = 30 msec (11) . Each spectrum required 11,250 scans and 15 min of signal accumulation. The signal was then zero-filled to 4 K and apodized with a 40-Hz Gaussian-exponential function before Fourier transformation. Other spectral acquisition parameters were as previously reported (11) . Spectrum A is a reference, natural-abundance 13C spectrum of human gastrocnemius muscle. The C-1 glycogen signal appears prominently at 100.5 ppm. Spectrum B was obtained after 100 min of [1-'3C]glucose/insulin infusion. The glycogen signal increased by a factor of 3.5. Spectrum C shows the difference between spectra A and B. spectra is shown by spectrum C. Clearly the glycogen signal had increased substantially and the subtraction errors in the nearby spectral regions are close to noise, showing the high reproducibility of the signal. Fig. 2 shows a plot of the 13C NMR signal amplitude of [1-13C] glycogen signal intensity, indicating that no significant glycogen degradation occurred. This result demonstrates that the increase in the C-1 glycogen signal represents net synthesis rather than isotopic turnover. Additional studies should allow us to understand the control of phosphorylase activity under conditions of glycogen synthesis (18, 19) .
From the NMR data, the rate of muscle glycogen synthesis during the time period between 45 and 90 min was calculated from the equation
Go f 45 where G90 and G45 represent the signal intensities ofglycogen at 90 and 45 min, times bracketing a period during which the rate of glycogen synthesis was constant; Go is the signal intensity of glycogen at time zero; and f is the percentage labeling of [1-13C] glucose in plasma from time 45 min to 90 min, which we measured to be 7.7%. This value of f was determined by using 1H NMR at 360 MHz on four samples obtained at 45, 60, 75, and 90 min. The factor 1.1 is the percent natural abundance of 13C, which was the degree of labeling in the basal glycogen, and K is the basal glycogen concentration.
The basal concentration (K) was calibrated by comparing the basal C-1 glycogen signal intensity against the signal obtained from a 4% (wt/vol) glycogen solution in 50 mM KCl in a cast shaped to match the leg. Any systematic error from this quantitation method will underestimate the actual glycogen concentration, since it assumes that 100% of the leg volume is muscle tissue. The reproducibility of the measurement has been established from repeated measurements on normal subjects to be within +±10o (14) . For the subject in this experiment, the basal glycogen concentration, in glucosyl units, was determined to be 55 ,mol/g of wet weight, which is in the low range of values (mean 83 ,umol/g, range 55-149 umol/g) previously reported by Hultman (20) for biopsy samples obtained from normal subjects. By substituting 55 prmol/g for K in the above equation, the muscle glycogen synthetic rate was calculated to be 0. 21 (12) . Both measurements (12, 21) showed a wide range around these means. Ifone assumes that the first ofthese values (38.8%) is correct, it can be calculated that total body muscle stored 91% of the infused glucose as glycogen. A calculation using the second value for muscle mass (27.2%) indicates that 64% of the glucose is stored as muscle glycogen. Even with this large uncertainty in the body muscle mass, it is clear that under the present experimental conditions of hyperglycemia and hyperinsulinemia, most of the infused glucose is stored by the body as muscle glycogen. Hence, the basic physiological question about where the majority of an infused glucose load is stored is answered by the present measurements. Looking ahead to the use of this method for studying pathological states, such as diabetes, it is clear that the ability to measure the rate of glycogen synthesis per gram of muscle tissue will provide an accurate method of distinguishing between normal and abnormal fluxes in this important insulin-regulated pathway. In addition to quantitating wholebody rates of glucose disposal, we can now focus upon quantitating the rate of glycogen formation in a clearly defined volume of muscle.
